Time-lapse morphokinetic assessment has low to moderate ability to predict euploidy when patient-and ovarian stimulation-related factors are taken into account with the use of clustered data analysis

Objective: To study whether time-lapse morphokinetic (TLM) assessment predicts ploidy status when patient-and ovarian stimulation-related factors are taken into account. Design: Retrospective cohort study. Setting: Private IVF clinic. Patient(s): In total, 103 consecutive patients (415 blastocysts) were included. All embryos were individually cultured in a time-lapse incubator from intracytoplasmic sperm injection up to trophectoderm biopsy. Following trophectoderm biopsy on day 5 or 6, blastocysts were vitrified and 23 TLM parameters were analyzed. Intervention(s): Correlations between patient-and ovarian stimulation-related factors and TLM parameters were tested in a multilevel mixed-effects linear regression model and assessed by means of intraclass correlation coefficient (ICC). Main Outcome Measure(s): Predictive ability of TLM parameters for euploidy. Result(s): The majority of TLM parameters had ICCs of 16%-47%. None of the patient-or ovarian stimulation-related factor had any systematic effect on any TLM parameter; however, body mass, total FSH dose, duration of infertility, number of previous cycles, antral follicle count, ovarian stimulation protocol, and E-2 on the trigger day had a significant impact on some TLM parameters. With the use of multilevel mixed-effects logistic regression analysis, of the ten TLM parameters that were initially noted to be significantly different among euploid and aneuploid blastocysts in the univariate analysis, only five remained significant. However, the areas under the receiver operating characteristic curves at regression analysis were low, ranging from 0.55 to 0.63. Conclusion(s): Five TLM parameters, all related to timing of blastocyst development, have limited ability to predict euploidy when patient- and ovarian stimulation-related factors are taken into account. (C) 2016 by American Society for Reproductive Medicine.